Graham Abra1, Manjula Kurella Tamura. 1. Division of Nephrology, Stanford University School of Medicine, Palo Alto, California 94304, USA.
Abstract
PURPOSE OF REVIEW: The past 15 years have seen tremendous growth in the initiation of dialysis at higher levels of kidney function in the setting of mixed evidence and at great societal economic cost. We review recent data on the early dialysis initiation trend, the clinical and economic impact of early dialysis initiation and the future implications for the management of advanced chronic kidney disease (CKD). RECENT FINDINGS: The percentage of patients who initiate dialysis with an estimated glomerular filtration rate (eGFR) above 10 ml/min/1.73m(2) is now greater than 50%, including 20% who initiate with an eGFR above 15 ml/min/1.73m(2). The drivers behind these findings are probably diverse but recent literature does not seem to support a higher symptom burden among the ageing CKD population as the major cause. The Initiating Dialysis Early And Late (IDEAL) trial provides guidance on the safety of waiting for symptoms or lower levels of estimated glomerular filtration rate prior to beginning dialysis. In addition, economic analyses based on the IDEAL and US Renal Data System findings suggest that significant cost savings could be achieved by reversing the early initiation trend. SUMMARY: These findings should help clinicians and policy makers looking to rein in costs while maintaining the quality of CKD care.
PURPOSE OF REVIEW: The past 15 years have seen tremendous growth in the initiation of dialysis at higher levels of kidney function in the setting of mixed evidence and at great societal economic cost. We review recent data on the early dialysis initiation trend, the clinical and economic impact of early dialysis initiation and the future implications for the management of advanced chronic kidney disease (CKD). RECENT FINDINGS: The percentage of patients who initiate dialysis with an estimated glomerular filtration rate (eGFR) above 10 ml/min/1.73m(2) is now greater than 50%, including 20% who initiate with an eGFR above 15 ml/min/1.73m(2). The drivers behind these findings are probably diverse but recent literature does not seem to support a higher symptom burden among the ageing CKD population as the major cause. The Initiating Dialysis Early And Late (IDEAL) trial provides guidance on the safety of waiting for symptoms or lower levels of estimated glomerular filtration rate prior to beginning dialysis. In addition, economic analyses based on the IDEAL and US Renal Data System findings suggest that significant cost savings could be achieved by reversing the early initiation trend. SUMMARY: These findings should help clinicians and policy makers looking to rein in costs while maintaining the quality of CKD care.
Authors: Vianda S Stel; Friedo W Dekker; David Ansell; Hans Augustijn; Francesco G Casino; Frederic Collart; Patrik Finne; George A Ioannidis; Mario Salomone; Jamie P Traynor; Oscar Zurriaga; Enrico Verrina; Kitty J Jager Journal: Nephrol Dial Transplant Date: 2009-06-10 Impact factor: 5.992
Authors: Bruce A Cooper; Pauline Branley; Liliana Bulfone; John F Collins; Jonathan C Craig; Margaret B Fraenkel; Anthony Harris; David W Johnson; Joan Kesselhut; Jing Jing Li; Grant Luxton; Andrew Pilmore; David J Tiller; David C Harris; Carol A Pollock Journal: N Engl J Med Date: 2010-06-27 Impact factor: 91.245
Authors: William F Clark; Yingbo Na; Steven J Rosansky; Jessica M Sontrop; Jennifer J Macnab; Richard J Glassock; Paul W Eggers; Kirby Jackson; Louise Moist Journal: CMAJ Date: 2010-12-06 Impact factor: 8.262
Authors: Seth Wright; Dalia Klausner; Bradley Baird; Mark E Williams; Theodore Steinman; Hongying Tang; Regina Ragasa; Alexander S Goldfarb-Rumyantzev Journal: Clin J Am Soc Nephrol Date: 2010-07-15 Impact factor: 8.237
Authors: B R Hemmelgarn; J Zhang; B J Manns; M Tonelli; E Larsen; W A Ghali; D A Southern; K McLaughlin; G Mortis; B F Culleton Journal: Kidney Int Date: 2006-03-08 Impact factor: 10.612
Authors: Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld Journal: J Am Soc Nephrol Date: 2007-09-12 Impact factor: 10.121
Authors: Ann M O'Hare; Susan P Wong; Margaret K Yu; Bruce Wynar; Mark Perkins; Chuan-Fen Liu; Jaclyn M Lemon; Paul L Hebert Journal: J Am Soc Nephrol Date: 2015-02-19 Impact factor: 10.121
Authors: Ann M O'Hare; Nancy Armistead; Wendy L Funk Schrag; Louis Diamond; Alvin H Moss Journal: Clin J Am Soc Nephrol Date: 2014-07-17 Impact factor: 8.237